EMERGENT BIOSOLUTIONS

Lobbying client · Maryland · filed 2025 to 2026

Pharmaceutical company.

$240,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (178553), not by name.

Firms hired 1

THE NICKLES GROUP, LLC $240,000 6 filings

Bills named in these filings 3

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

1 filing
HR 8800
National Defense Authorization Act for Fiscal Year 2027

1 filing
S 4784
National Defense Authorization Act for Fiscal Year 2027

1 filing

Reported by year 2 years

2026 $80,000 2 filings
2025 $160,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
Office of Management & Budget (OMB) 6
SENATE 6

Recent filings 6 total

Q2

THE NICKLES GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 15, 2026

View → Q1

THE NICKLES GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 income · posted Apr 15, 2026

View → Q4

THE NICKLES GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $40,000 income · posted Jan 20, 2026

View → Q3

THE NICKLES GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2

THE NICKLES GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $40,000 income · posted Jul 7, 2025

View → Q1

THE NICKLES GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.